Current Market Landscape and Emerging Opportunities The Nonalcoholic Steatohepatitis Market has evolved into a critical focus area for pharmaceutical innovation. With approximately 6.5% of the global population affected by advanced liver fibrosis associated with NASH, the therapeutic landscape presents unprecedented opportunities for market expansion and patient care improvement....